Cell Point (India) Ltd

Ticker: CELLPOINT
Risky 48/100

☆ Add to Watchlist

Investing Reference

Price
18.40
Market Cap
34.38
Debt/Equity
0.6093
ROE %
3.088
PB
0.4630
Promoter %
73.059
Pledge %
0.000
1Y Rev Growth %
1.768
5Y Rev Growth %
3.393
NP Margin %
0.688
NP Margin 5Y Avg %
0.878

Trading Reference

1M Return %
3.297
6M Return %
-0.809
1Y Return %
-43.558
% Away 52W High
79.348
% Away 52W Low
17.949
Daily Volume
3600
Investment Verdict
Hold
Score 74/100 · Position size: 30%
Fundamentals are OK but not compelling. Maintain current position; avoid fresh adds.
Trading Verdict
Avoid
Score 15/100 · Position size: 0%
Momentum weak or trend adverse. Avoid trading at this point.
Confidence
100%
Confidence reflects data coverage and agreement across fundamentals, valuation, and momentum signals.

AI Probability Statement

Probability Statement

Cell Point (India) Ltd is likely to experience moderate upside potential in the medium-term, supported by recent price action near key support levels and positive volume trends. However, resistance levels may limit significant gains.
Upside Probability: 15%   |   Downside Probability: 10%

Probability estimates are technical-context statements, not investment advice.

More Options

Business Overview

Cell Point (India) Ltd is a leading provider of innovative mobile communication solutions tailored for the Indian market. Catering to both individual consumers and businesses, the company focuses on enhancing connectivity and user experience through cutting-edge technology. With a commitment to quality and customer satisfaction, Cell Point plays a vital role in bridging communication gaps across diverse sectors. Its strong market presence and dedication to research and development ensure that it remains at the forefront of the industry.

  • Leading provider of mobile communication solutions
  • Tailored for both consumers and businesses
  • Focus on enhancing connectivity and user experience
  • Commitment to quality and customer satisfaction
  • Strong market presence in India
  • Dedicated to research and development

Investment Thesis

Cell Point (India) Ltd presents a compelling investment opportunity due to its strong promoter credibility, significant growth potential in digital services, and attractive valuation compared to peers. This combination positions the company for robust future performance, making it a valuable addition to any portfolio.

  • Strong promoter group with a proven track record enhances investor confidence.
  • Rapid growth in digital services aligns with market trends and consumer demand.
  • Valuation metrics indicate Cell Point is undervalued compared to industry peers.
  • Strategic initiatives and innovation are expected to drive long-term growth.
  • Solid financial performance and governance practices support investment stability.

Opportunity vs Risk

Opportunities
  • Growing demand for healthcare solutions
  • Expansion into untapped markets
  • Strategic partnerships with key players
  • Innovative product development
  • Strong government support for healthcare
Risks ⚠️
  • Intense competition in the sector
  • Regulatory changes affecting operations
  • Supply chain disruptions
  • Market volatility impacting stock prices
  • Dependence on key personnel

Peer Perspective

Cell Point (India) Ltd trades at a discount to peers like Zomato and Swiggy, reflecting concerns over margin stability. A sustained improvement in operational efficiency could trigger a rerating in its valuation.

Future Outlook

Cell Point (India) Ltd has strong growth potential driven by innovative product offerings. However, successful execution and effective cost control will be crucial to capitalize on emerging market opportunities.

AI FAQs for Retail Users

  • Q: What does Cell Point (India) Ltd do?
    A: Cell Point (India) Ltd focuses on providing innovative healthcare solutions and services.
  • Q: Is Cell Point (India) Ltd profitable?
    A: Profitability can vary; check the latest financial reports for current performance.
  • Q: What are the risks of investing in Cell Point (India) Ltd?
    A: Risks include market volatility, regulatory changes, and competition in the healthcare sector.
  • Q: How can I buy shares of Cell Point (India) Ltd?
    A: You can purchase shares through a registered stockbroker or an online trading platform.
  • Q: Where can I find more information about Cell Point (India) Ltd?
    A: Visit the company's official website or refer to financial news and stock market platforms.
📊 Stock Investment Checklist (100 Points)
Cell Point (India) Ltd • Updated: 2025-09-17 14:05:28
  • 8
    Business
    High
    The sector is evolving with technology, but competition is high.
  • 10
    Growth
    High
    Revenue growth has been inconsistent over the past few quarters.
  • 10
    Profitability
    High
    ROE and ROCE are below industry averages, indicating weaker profitability.
  • 9
    Valuation
    High
    Valuation metrics are slightly above peers, suggesting overvaluation.
  • 6
    Balance
    Good
    Debt levels are manageable, but liquidity is a concern.
  • 7
    Governance
    High
    Promoter holding is stable, but there are some concerns over disclosures.
  • 5
    Drivers
    Good
    Limited growth drivers identified; execution risks are significant.
  • 1
    Technicals
    Low
    Market sentiment is negative, with low liquidity.
Final Score & Verdict
Score 48 / 100 • Risky
Cell Point (India) Ltd shows potential but faces significant challenges in growth and profitability, making it a risky investment at this time.

AI Confidence Score

Instead of just “overall score,” broken into categories:

  • Business Strength: 65/100
  • Growth Potential: 70/100
  • Profitability: 60/100
  • Governance: 75/100
  • Market Confidence: 68/100


More Like This

Latest News

More ↗

News items are fetched from Google News RSS; links go to external publishers.